Non-adherence among patients initiating antiretroviral therapy: A challenge for health professionals in Brazil

AIDS

Volumn 19, Issue SUPPL. 4, 2005, Pages

  Bonolo, Palmira De F ^a,e   César, Cibele C ^b   Acúrcio, Francisco A ^a,c   Ceccato, Maria Das Graças B ^a   Menezes De Pádua, Cristiane A ^a   Álvares, Juliana ^a   Campos, Lorenza N ^a   Carmo, Ricardo A ^d   Guimarães, Mark D C ^a,c  

^a Faculty of Medicine   (Brazil)

^b Institute of Exact Sciences   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d Eduardo de Menezes Hospital   (Brazil)

^e Division of Epidemiology   (Brazil)

Author keywords

Adherence; Antiretroviral therapy; Brazil; HIV; Prospective study

Indexed keywords

ANTIVIRUS AGENT; EFAVIRENZ; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; ZIDOVUDINE;

ADULT; ALCOHOL ABUSE; ARTICLE; BRAZIL; CONFIDENCE INTERVAL; CONTROLLED STUDY; FATIGUE; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HAZARD ASSESSMENT; HEALTH PRACTITIONER; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NAUSEA; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; SELF REPORT; STOMACH PAIN; UNEMPLOYMENT;

EID: 27944489164     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000191484.84661.2b     Document Type: Article

References (26)

1. Hacker MA, Petersen MI, Enriquez M, Bastos FI. Highly active antiretroviral therapy in Brazil: the chalenge of universal access in a context of social inequality. Pan Am J Public Health 2004; 16:78-83.
2. Marins JRP, Jamal LF, Chen S, Hudes ES, Júnior AB, Barros MBA, et al. Current survival of AIDS-patients in Brazil: The results of a national effort. Available at: http://www.aids.gov.br/final/biblioteca/bol_marco_2002/ artigo1.htm. Accessed: June 1, 2004
3. Guimarães MDC. Temporal trends in AIDS-associated opportunistic infection in Brazil, 1980-1999. Rep Public Health 2000; 16:21-36.
4. Teixeira PR, Vitória MA, Barcarolo J. Antiretroviral treatment in resource-poor settings:the Brazilian experience. AIDS 2004; 18 (Suppl. 3):S5-S7.
5. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133:21-30.
6. Nemes MIB, Carvalho HB, Souza MFM. Antiretroviral therapy adherence in Brazil. AIDS 2004; 18 (Suppl. 3):S15-S20.
7. Walsh JC, Sherr L, Adherence Strategy Group. An assessment of current HIV treatment adherence services in the UK. AIDS Care 2002; 14:329-334.
8. Andreo C, Bouhnik AD, Soletti J, Bertholon DR, Moatti JP, Rossert H, et al. Non-compliance in HIV infected patients, supported buy a community association. Sante Publique 2001; 13:249-262.
9. Oyugi JH, Byakika-Tusiime J, Charlebois ED, Kityo C, Mugerwa R, Mugyenyi P, et al. Uganda: multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J Acquir Immune Defic Syndr 2004; 36:1100-1102.
10. Duran S, Spire B, Raffi F, Walter V, Bouchour D, Journot V, et al., and the APROCO Cohort Study Group. Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART. HIV Clin Trials 2001; 2:38-45.
11. Mehta S, Moore RD, Graham NMH. Potential factors affecting adherence with HIV therapy [Editorial review]. AIDS 1997; 11:1665-1670.
12. Fogarty L, Roter D, Larson S, Burke J, Gillespie J, Levy R. Patient adherence to HIV medication regimens: a review of published and abstract reports. Patient Educ Counsel 2002; 46:93-108.
13. Carvalho CV, Duarte DB, Hamann EM, Bicudo E, Laguardia J. Predictors of compliance with highly active antiretroviral therapy in Brasília, Distrito Federal, Brazil, 1999-2000 [in Portuguese]. Rep Public Health 2003; 19:593-604.
14. Lignani LJ, Greco DB, Carneiro M. Assessment of the compliance to antiretroviral drugs among HIV/AIDS patients [in Portuguese]. J Public Health 2001; 35:495-501.
15. Brazilian Ministry of Health. Recommendations for antiretroviral therapy in HIV-infected adults and adolescents - 2002/2003. Available at: http://www.aids.gov.br/final/tratamento/consenso_english_2003.htm. Accessed: June 1, 2004
16. Centers for Disease Control and Prevention, 1993. Revised classification system for HIV infection and expanded surveillance case definitions for AIDS among adolescents and adults. MMWR 1992; 41 (RR-17):1-19.
17. Ceccato MGB, Acurcio FA, Bonolo PF, Rocha GM, Guimarães MDC. HIV patient's understanding of information on antiretroviral therapy [in Portuguese]. Rep Public Health 2004; 20:1338-1397.
18. Cox DR, Oakes D. Analysis of survival data. New York: Chapman and Hall; 1984.
19. Hosmer DW Jr, Lemeshow S. Applied survival analysis: regression modeling of time to event data. New York: Wiley; 1999.
20. Rodrigues-Júnior AL, Castilho EA. The AIDS epidemic in Brazil, 1991-2000: space-time description [in Portuguese]. Rev Soc Bras Med Trop 2004; 37:312-317.
21. Arici C, Ripamonti D, Maggiolo F, Rizzi M, Finazzi MG, Pezzotti P, et al. Factors associated with the failure of HIV-positive persons to return for scheduled medical visits. HIV Clin Trials 2002; 3:52-57.
22. Spire B, Duran S, Souville M, Leport C, Raffi F, Moatti JP, and the APROCO cohort study group. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. Soc Sci Med 2002; 54:1481-1496.
23. Rodrigues CS, Guimarães MDC, Acúrcio FA, César CC. Interruption of outpatient clinical care of HIV-infected patients [in Portuguese]. J Public Health 2003; 37:183-190.
24. Kleeberger CA, Buechner J, Palella F, Detels R, Riddler S, Godfrey R, et al. Changes in adherence to highly active antiretroviral therapy medications in the Multicenter AIDS Cohort Study. AIDS 2004; 18:683-688.
25. Katherine VH, Singer J, O'Shaughnessy MV, Montaner JSG, Hogg RS. Intentional nonadherence due to adverse symptoms associated with antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 31:211-217.
26. Lang L, Nagin N, Gerther M, Masci M. HIV infected women: treatment adherence. AIDS 2000; 14 (Suppl. 4):S55.